Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates
M. Osaki (Kobe, Japan), R. Tachikawa (Kobe, Japan), Y. Shima (Kobe, Japan), Y. Shimada (Kobe, Japan), A. Matsunashi (Kobe, Japan), K. Hosoya (Kobe, Japan), R. Hirabayashi (Kobe, Japan), Y. Sato (Kobe, Japan), K. Nagata (Kobe, Japan), A. Nakagawa (Kobe, Japan), K. Tomii (Kobe, Japan)
Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Osaki (Kobe, Japan), R. Tachikawa (Kobe, Japan), Y. Shima (Kobe, Japan), Y. Shimada (Kobe, Japan), A. Matsunashi (Kobe, Japan), K. Hosoya (Kobe, Japan), R. Hirabayashi (Kobe, Japan), Y. Sato (Kobe, Japan), K. Nagata (Kobe, Japan), A. Nakagawa (Kobe, Japan), K. Tomii (Kobe, Japan). Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates. 2746
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: